Compare SRL & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRL | PYPD |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.0M | 77.4M |
| IPO Year | 1996 | 2014 |
| Metric | SRL | PYPD |
|---|---|---|
| Price | $8.61 | $4.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 27.0K | ★ 39.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.13 | $2.30 |
| 52 Week High | $10.39 | $5.12 |
| Indicator | SRL | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 43.67 |
| Support Level | $8.66 | $4.01 |
| Resistance Level | $9.60 | $4.38 |
| Average True Range (ATR) | 0.29 | 0.18 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 30.00 | 41.86 |
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.